Skip to search formSkip to main contentSkip to account menu

WAY 100635

Known as: WAY-100,635, WAY 100,635, WAY-100635 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
Interaction of new antidepressants with sigma-1 receptor chaperones and their potentiation of neurite outgrowth in PC12 cells.
Highly Cited
2006
Highly Cited
2006
Lemon oil vapor causes an anti-stress effect via modulating the 5-HT and DA activities in mice
Highly Cited
2005
Highly Cited
2005
Effects of Acute and Long-Term Administration of Escitalopram and Citalopram on Serotonin Neurotransmission: an In Vivo Electrophysiological Study in Rat Brain
The present study was undertaken to compare the acute and long-term effects of escitalopram and citalopram on rat brain 5-HT… 
Highly Cited
2004
Highly Cited
2004
Roles of serotonin receptor subtypes for the antinociception of 5-HT in the spinal cord of rats.
Highly Cited
2002
Highly Cited
2002
5-HT1A receptor antagonist administration decreases cell proliferation in the dentate gyrus
Highly Cited
2001
Highly Cited
2001
Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY…
The possible role of 5-HT1A and 5-HT2C receptors in the anxiety induced by fear, acute treatment with SSRI antidepressants or the… 
Highly Cited
2001
Highly Cited
2001
Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors
Highly Cited
1996
Highly Cited
1996
Role of 5-HT1A receptors in the effects of acute and chronic fluoxetine on extracellular serotonin in the frontal cortex
Highly Cited
1995
Highly Cited
1995
A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635.
Review
1995
Review
1995
Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)